APO Research
Talk to an analyst

APO RESEARCH · REPORT

Assisted Reproductive Technologies Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Assisted Reproductive Technologies Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchAssisted Reproductive Technologies Medications Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Assisted Reproductive Technologies Medications Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Assisted Reproductive Technologies Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Assisted Reproductive Technologies Medications Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Assisted Reproductive Technologies Medications Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Assisted Reproductive Technologies Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Assisted Reproductive Technologies Medications include Zhejiang Xianju, Merck Serono, Livzon Pharmaceutical, Changchun GeneScience, Hybio Pharmaceutical, Solvay, Organon, Ipsen and Ferring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Assisted Reproductive Technologies Medications market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Assisted Reproductive Technologies Medications and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Assisted Reproductive Technologies Medications revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Assisted Reproductive Technologies Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Assisted Reproductive Technologies Medications Segment by Company

Zhejiang Xianju

Merck Serono

Livzon Pharmaceutical

Changchun GeneScience

Hybio Pharmaceutical

Solvay

Organon

Ipsen

Ferring

Besins

Assisted Reproductive Technologies Medications Segment by Type

Ovulation Stimulation Drugs

Luteal Support Medications

Down-Regulation Drugs

Ovulation Inducing Drugs

Assisted Reproductive Technologies Medications Segment by Application

Specialty & Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Assisted Reproductive Technologies Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Assisted Reproductive Technologies Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Assisted Reproductive Technologies Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Assisted Reproductive Technologies Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Assisted Reproductive Technologies Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Assisted Reproductive Technologies Medications industry.

Chapter 3: Detailed analysis of Assisted Reproductive Technologies Medications companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Assisted Reproductive Technologies Medicationsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Ovulation Stimulation Drugs Table 3. Key Players of Luteal Support Medications Table 4. Key Players of Down-Regulation Drugs Table 3. Key Players of Ovulation Inducing Drugs Table 4. Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Specialty & Retail Pharmacy Table 6. Key Players of Hospital Pharmacy Table 7. Key Players of Online Pharmacy Table 8. Global Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Assisted Reproductive Technologies Medications Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Assisted Reproductive Technologies Medications Market Share by Region (2021-2026) Table 11. Global Assisted Reproductive Technologies Medications Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Assisted Reproductive Technologies Medications Market Share by Region (2027-2032) Table 13. Assisted Reproductive Technologies Medications Industry Trends Table 14. Assisted Reproductive Technologies Medications Industry Drivers Table 15. Assisted Reproductive Technologies Medications Industry Opportunities and Challenges Table 16. Assisted Reproductive Technologies Medications Industry Restraints Table 17. Global Assisted Reproductive Technologies Medications Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Assisted Reproductive Technologies Medications Revenue Market Share by Company (2021-2026) Table 19. Global Assisted Reproductive Technologies Medications Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Assisted Reproductive Technologies Medications Key Company Head Office and Area Served Table 21. Global Assisted Reproductive Technologies Medications Company, Product Type & Application Table 22. Global Assisted Reproductive Technologies Medications Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Assisted Reproductive Technologies Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Assisted Reproductive Technologies Medications Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Assisted Reproductive Technologies Medications Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2021-2026) Table 29. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2027-2032) Table 30. Global Assisted Reproductive Technologies Medications Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Assisted Reproductive Technologies Medications Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Assisted Reproductive Technologies Medications Revenue Market Share by Application (2021-2026) Table 34. Global Assisted Reproductive Technologies Medications Revenue Market Share by Application (2027-2032) Table 35. Zhejiang Xianju Company Information Table 36. Zhejiang Xianju Business Overview Table 37. Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Zhejiang Xianju Assisted Reproductive Technologies Medications Product Portfolio Table 39. Zhejiang Xianju Recent Development Table 40. Merck Serono Company Information Table 41. Merck Serono Business Overview Table 42. Merck Serono Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Serono Assisted Reproductive Technologies Medications Product Portfolio Table 44. Merck Serono Recent Development Table 45. Livzon Pharmaceutical Company Information Table 46. Livzon Pharmaceutical Business Overview Table 47. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio Table 49. Livzon Pharmaceutical Recent Development Table 50. Changchun GeneScience Company Information Table 51. Changchun GeneScience Business Overview Table 52. Changchun GeneScience Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Changchun GeneScience Assisted Reproductive Technologies Medications Product Portfolio Table 54. Changchun GeneScience Recent Development Table 55. Hybio Pharmaceutical Company Information Table 56. Hybio Pharmaceutical Business Overview Table 57. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio Table 59. Hybio Pharmaceutical Recent Development Table 60. Solvay Company Information Table 61. Solvay Business Overview Table 62. Solvay Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Solvay Assisted Reproductive Technologies Medications Product Portfolio Table 64. Solvay Recent Development Table 65. Organon Company Information Table 66. Organon Business Overview Table 67. Organon Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Organon Assisted Reproductive Technologies Medications Product Portfolio Table 69. Organon Recent Development Table 70. Ipsen Company Information Table 71. Ipsen Business Overview Table 72. Ipsen Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Ipsen Assisted Reproductive Technologies Medications Product Portfolio Table 74. Ipsen Recent Development Table 75. Ferring Company Information Table 76. Ferring Business Overview Table 77. Ferring Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Ferring Assisted Reproductive Technologies Medications Product Portfolio Table 79. Ferring Recent Development Table 80. Besins Company Information Table 81. Besins Business Overview Table 82. Besins Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Besins Assisted Reproductive Technologies Medications Product Portfolio Table 84. Besins Recent Development Table 85. North America Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Assisted Reproductive Technologies Medications Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Assisted Reproductive Technologies Medications Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) Table 91. North America Assisted Reproductive Technologies Medications Market Size by Country (2027-2032) Table 92. Europe Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Assisted Reproductive Technologies Medications Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Assisted Reproductive Technologies Medications Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) Table 98. Europe Assisted Reproductive Technologies Medications Market Size by Country (2027-2032) Table 99. China Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 100. China Assisted Reproductive Technologies Medications Market Size by Type (2027-2032) & (US$ Million) Table 101. China Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 102. China Assisted Reproductive Technologies Medications Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Assisted Reproductive Technologies Medications Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Assisted Reproductive Technologies Medications Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) Table 109. Asia Assisted Reproductive Technologies Medications Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Assisted Reproductive Technologies Medications Product Image Figure 2. Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Assisted Reproductive Technologies Medications Market Share by Type: 2025 VS 2032 Figure 4. Ovulation Stimulation Drugs Image Figure 5. Luteal Support Medications Image Figure 6. Down-Regulation Drugs Image Figure 7. Ovulation Inducing Drugs Image Figure 8. Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Assisted Reproductive Technologies Medications Market Share by Application: 2025 VS 2032 Figure 10. Specialty & Retail Pharmacy Image Figure 11. Hospital Pharmacy Image Figure 12. Online Pharmacy Image Figure 13. Global Assisted Reproductive Technologies Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 15. Global Assisted Reproductive Technologies Medications Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Assisted Reproductive Technologies Medications Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Assisted Reproductive Technologies Medications Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Assisted Reproductive Technologies Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Assisted Reproductive Technologies Medications Revenue Market Share by Type (2021-2032) Figure 22. Global Assisted Reproductive Technologies Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Assisted Reproductive Technologies Medications Revenue Market Share by Application (2021-2032) Figure 24. North America Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 25. North America Assisted Reproductive Technologies Medications Market Share by Type (2021-2032) Figure 26. North America Assisted Reproductive Technologies Medications Market Share by Application (2021-2032) Figure 27. North America Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 28. United States Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 29. Canada Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 31. Europe Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 32. Europe Assisted Reproductive Technologies Medications Market Share by Type (2021-2032) Figure 33. Europe Assisted Reproductive Technologies Medications Market Share by Application (2021-2032) Figure 34. Europe Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 35. Germany Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 36. France Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 38. Italy Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 39. Russia Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 41. China Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 42. China Assisted Reproductive Technologies Medications Market Share by Type (2021-2032) Figure 43. China Assisted Reproductive Technologies Medications Market Share by Application (2021-2032) Figure 44. Asia Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 45. Asia Assisted Reproductive Technologies Medications Market Share by Type (2021-2032) Figure 46. Asia Assisted Reproductive Technologies Medications Market Share by Application (2021-2032) Figure 47. Asia Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 48. Japan Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 52. India Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 53. Australia Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 58. Brazil Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 63. UAE Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 65. Chile Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Ovulation Stimulation Drugs
  • Luteal Support Medications
  • Down-Regulation Drugs
  • Ovulation Inducing Drugs
Applications
  • Specialty & Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Zhejiang Xianju
  • Merck Serono
  • Livzon Pharmaceutical
  • Changchun GeneScience
  • Hybio Pharmaceutical
  • Solvay
  • Organon
  • Ipsen
  • Ferring
  • Besins

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Ovulation Stimulation Drugs
  5. 1.2.3 Luteal Support Medications
  6. 1.2.4 Down-Regulation Drugs
  7. 1.2.5 Ovulation Inducing Drugs
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Assisted Reproductive Technologies Medications Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Specialty & Retail Pharmacy
  11. 1.3.3 Hospital Pharmacy
  12. 1.3.4 Online Pharmacy
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Assisted Reproductive Technologies Medications Growth Trends by Region
  15. 1.5.1 Global Assisted Reproductive Technologies Medications Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Assisted Reproductive Technologies Medications Market Size by Region (2021-2026)
  17. 1.5.3 Assisted Reproductive Technologies Medications Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Assisted Reproductive Technologies Medications Market Dynamics
  1. 2.1 Assisted Reproductive Technologies Medications Industry Trends
  2. 2.2 Assisted Reproductive Technologies Medications Industry Drivers
  3. 2.3 Assisted Reproductive Technologies Medications Industry Opportunities and Challenges
  4. 2.4 Assisted Reproductive Technologies Medications Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Assisted Reproductive Technologies Medications Revenue by Company (2021-2026)
  2. 3.2 Global Assisted Reproductive Technologies Medications Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Assisted Reproductive Technologies Medications Key Company Head office and Area Served
  4. 3.4 Global Assisted Reproductive Technologies Medications Company, Product Type & Application
  5. 3.5 Global Assisted Reproductive Technologies Medications Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Assisted Reproductive Technologies Medications Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Assisted Reproductive Technologies Medications Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Assisted Reproductive Technologies Medications Tier 1, Tier 2, and Tier 3
4 Assisted Reproductive Technologies Medications Market by Type
  1. 4.1 Global Assisted Reproductive Technologies Medications Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Assisted Reproductive Technologies Medications Market Size by Type (2021-2032)
  3. 4.3 Global Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2032)
5 Assisted Reproductive Technologies Medications Market by Application
  1. 5.1 Global Assisted Reproductive Technologies Medications Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Assisted Reproductive Technologies Medications Market Size by Application (2021-2032)
  3. 5.3 Global Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Zhejiang Xianju
  2. 6.1.1 Zhejiang Xianju Company Information
  3. 6.1.2 Zhejiang Xianju Business Overview
  4. 6.1.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Zhejiang Xianju Assisted Reproductive Technologies Medications Product Portfolio
  6. 6.1.5 Zhejiang Xianju Recent Developments
  7. 6.2 Merck Serono
  8. 6.2.1 Merck Serono Company Information
  9. 6.2.2 Merck Serono Business Overview
  10. 6.2.3 Merck Serono Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Serono Assisted Reproductive Technologies Medications Product Portfolio
  12. 6.2.5 Merck Serono Recent Developments
  13. 6.3 Livzon Pharmaceutical
  14. 6.3.1 Livzon Pharmaceutical Company Information
  15. 6.3.2 Livzon Pharmaceutical Business Overview
  16. 6.3.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio
  18. 6.3.5 Livzon Pharmaceutical Recent Developments
  19. 6.4 Changchun GeneScience
  20. 6.4.1 Changchun GeneScience Company Information
  21. 6.4.2 Changchun GeneScience Business Overview
  22. 6.4.3 Changchun GeneScience Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Changchun GeneScience Assisted Reproductive Technologies Medications Product Portfolio
  24. 6.4.5 Changchun GeneScience Recent Developments
  25. 6.5 Hybio Pharmaceutical
  26. 6.5.1 Hybio Pharmaceutical Company Information
  27. 6.5.2 Hybio Pharmaceutical Business Overview
  28. 6.5.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio
  30. 6.5.5 Hybio Pharmaceutical Recent Developments
  31. 6.6 Solvay
  32. 6.6.1 Solvay Company Information
  33. 6.6.2 Solvay Business Overview
  34. 6.6.3 Solvay Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Solvay Assisted Reproductive Technologies Medications Product Portfolio
  36. 6.6.5 Solvay Recent Developments
  37. 6.7 Organon
  38. 6.7.1 Organon Company Information
  39. 6.7.2 Organon Business Overview
  40. 6.7.3 Organon Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Organon Assisted Reproductive Technologies Medications Product Portfolio
  42. 6.7.5 Organon Recent Developments
  43. 6.8 Ipsen
  44. 6.8.1 Ipsen Company Information
  45. 6.8.2 Ipsen Business Overview
  46. 6.8.3 Ipsen Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ipsen Assisted Reproductive Technologies Medications Product Portfolio
  48. 6.8.5 Ipsen Recent Developments
  49. 6.9 Ferring
  50. 6.9.1 Ferring Company Information
  51. 6.9.2 Ferring Business Overview
  52. 6.9.3 Ferring Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Ferring Assisted Reproductive Technologies Medications Product Portfolio
  54. 6.9.5 Ferring Recent Developments
  55. 6.10 Besins
  56. 6.10.1 Besins Company Information
  57. 6.10.2 Besins Business Overview
  58. 6.10.3 Besins Assisted Reproductive Technologies Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Besins Assisted Reproductive Technologies Medications Product Portfolio
  60. 6.10.5 Besins Recent Developments
7 North America
  1. 7.1 North America Assisted Reproductive Technologies Medications Market Size (2021-2032)
  2. 7.2 North America Assisted Reproductive Technologies Medications Market Size by Type
  3. 7.2.1 North America Assisted Reproductive Technologies Medications Market Size by Type (2021-2026)
  4. 7.2.2 North America Assisted Reproductive Technologies Medications Market Size by Type (2027-2032)
  5. 7.2.3 North America Assisted Reproductive Technologies Medications Market Share by Type (2021-2032)
  6. 7.3 North America Assisted Reproductive Technologies Medications Market Size by Application
  7. 7.3.1 North America Assisted Reproductive Technologies Medications Market Size by Application (2021-2026)
  8. 7.3.2 North America Assisted Reproductive Technologies Medications Market Size by Application (2027-2032)
  9. 7.3.3 North America Assisted Reproductive Technologies Medications Market Share by Application (2021-2032)
  10. 7.4 North America Assisted Reproductive Technologies Medications Market Size by Country
  11. 7.4.1 North America Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  13. 7.4.3 North America Assisted Reproductive Technologies Medications Market Size by Country (2027-2032)
  14. 7.4.4 North America Assisted Reproductive Technologies Medications Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Assisted Reproductive Technologies Medications Market Size (2021-2032)
  2. 8.2 Europe Assisted Reproductive Technologies Medications Market Size by Type
  3. 8.2.1 Europe Assisted Reproductive Technologies Medications Market Size by Type (2021-2026)
  4. 8.2.2 Europe Assisted Reproductive Technologies Medications Market Size by Type (2027-2032)
  5. 8.2.3 Europe Assisted Reproductive Technologies Medications Market Share by Type (2021-2032)
  6. 8.3 Europe Assisted Reproductive Technologies Medications Market Size by Application
  7. 8.3.1 Europe Assisted Reproductive Technologies Medications Market Size by Application (2021-2026)
  8. 8.3.2 Europe Assisted Reproductive Technologies Medications Market Size by Application (2027-2032)
  9. 8.3.3 Europe Assisted Reproductive Technologies Medications Market Share by Application (2021-2032)
  10. 8.4 Europe Assisted Reproductive Technologies Medications Market Size by Country
  11. 8.4.1 Europe Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  13. 8.4.3 Europe Assisted Reproductive Technologies Medications Market Size by Country (2027-2032)
  14. 8.4.4 Europe Assisted Reproductive Technologies Medications Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Assisted Reproductive Technologies Medications Market Size (2021-2032)
  2. 9.2 China Assisted Reproductive Technologies Medications Market Size by Type
  3. 9.2.1 China Assisted Reproductive Technologies Medications Market Size by Type (2021-2026)
  4. 9.2.2 China Assisted Reproductive Technologies Medications Market Size by Type (2027-2032)
  5. 9.2.3 China Assisted Reproductive Technologies Medications Market Share by Type (2021-2032)
  6. 9.3 China Assisted Reproductive Technologies Medications Market Size by Application
  7. 9.3.1 China Assisted Reproductive Technologies Medications Market Size by Application (2021-2026)
  8. 9.3.2 China Assisted Reproductive Technologies Medications Market Size by Application (2027-2032)
  9. 9.3.3 China Assisted Reproductive Technologies Medications Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Assisted Reproductive Technologies Medications Market Size (2021-2032)
  2. 10.2 Asia Assisted Reproductive Technologies Medications Market Size by Type
  3. 10.2.1 Asia Assisted Reproductive Technologies Medications Market Size by Type (2021-2026)
  4. 10.2.2 Asia Assisted Reproductive Technologies Medications Market Size by Type (2027-2032)
  5. 10.2.3 Asia Assisted Reproductive Technologies Medications Market Share by Type (2021-2032)
  6. 10.3 Asia Assisted Reproductive Technologies Medications Market Size by Application
  7. 10.3.1 Asia Assisted Reproductive Technologies Medications Market Size by Application (2021-2026)
  8. 10.3.2 Asia Assisted Reproductive Technologies Medications Market Size by Application (2027-2032)
  9. 10.3.3 Asia Assisted Reproductive Technologies Medications Market Share by Application (2021-2032)
  10. 10.4 Asia Assisted Reproductive Technologies Medications Market Size by Country
  11. 10.4.1 Asia Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  13. 10.4.3 Asia Assisted Reproductive Technologies Medications Market Size by Country (2027-2032)
  14. 10.4.4 Asia Assisted Reproductive Technologies Medications Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst